Results 221 to 230 of about 205,179 (309)

Clinical proteomics [PDF]

open access: yesOsteoarthritis and Cartilage, 2013
openaire   +2 more sources

In-Depth Comparison of Reagent-Based Digestion Methods and Two Commercially Available Kits for Bottom-Up Proteomics

open access: yesACS Omega
Travis Uslan   +5 more
doaj   +1 more source

Chemical Approaches for Functionally Probing the Proteome [PDF]

open access: hybrid, 2002
Doron C. Greenbaum   +6 more
openalex   +1 more source

Proteomic Profiling of the Large‐Vessel Vasculitis Spectrum Identifying Shared Signatures of Innate Immune Activation and Stromal Remodeling

open access: yesArthritis &Rheumatology, EarlyView.
Objective Takayasu arteritis (TAK) and giant cell arteritis (GCA), the most common forms of large‐vessel vasculitis (LVV), can result in serious morbidity. Understanding the molecular basis of LVV should aid in developing better biomarkers and treatments. Methods Plasma proteomic profiling of 184 proteins was performed in two cohorts. Cohort 1 included
Robert T. Maughan   +15 more
wiley   +1 more source

Plasma proteome analysis of rheumatic patients reveals differences in fingerprints based on cardiovascular history: a pilot study. [PDF]

open access: yesProteome Sci
Hansildaar R   +5 more
europepmc   +1 more source

Central Functions of the Lumenal and Peripheral Thylakoid Proteome of Arabidopsis Determined by Experimentation and Genome-Wide Prediction [PDF]

open access: bronze, 2002
Jean‐Benoît Peltier   +10 more
openalex   +1 more source

Variability in intestinal drug metabolizing enzymes and transporters in Crohn's disease and potential impact on oral drug absorption

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims The aim of study was to generate quantitative data on the abundance of drug‐metabolizing enzymes and transporters (DMETs) in inflamed and non‐inflamed Crohn's disease (CD) ileum and colon, for incorporation into physiologically based pharmacokinetic (PBPK) models, enabling prediction of oral drugs' pharmacokinetics (PK) perturbation in CD patients.
Sarah Alrubia   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy